BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3496073)

  • 1. Is contact activation of the coagulation system involved in the genesis of the first-use syndrome?
    Vaziri ND
    Artif Organs; 1987 Apr; 11(2):163-4. PubMed ID: 3496073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plate, coil, and hollow-fiber cuprammonium cellulose dialyzers: discrepancy between incidence of anaphylactic reactions and degree of complement activation.
    Daugirdas JT; Potempa LD; Dinh N; Gandhi VC; Ivanovich PT; Ing TS
    Artif Organs; 1987 Apr; 11(2):140-3. PubMed ID: 3593043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of complement activation by hemodialysis membranes.
    Cheung AK; Henderson LW
    Am J Nephrol; 1986; 6(2):81-91. PubMed ID: 3518458
    [No Abstract]   [Full Text] [Related]  

  • 4. Complement activation during hemodialysis: laboratory evaluation of hemodialyzers.
    Chenoweth DE; Henderson LW
    Artif Organs; 1987 Apr; 11(2):155-62. PubMed ID: 3496072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement activation and hypersensitivity reactions to dialysis membranes.
    Hakim RM; Breillatt J; Lazarus JM; Port FK
    N Engl J Med; 1984 Oct; 311(14):878-82. PubMed ID: 6332276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes.
    Chenoweth DE; Cheung AK; Henderson LW
    Kidney Int; 1983 Dec; 24(6):764-9. PubMed ID: 6609269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypersensitivity reactions during haemodialysis: role of complement fragments and ethylene oxide antibodies.
    Lemke HD; Heidland A; Schaefer RM
    Nephrol Dial Transplant; 1990; 5(4):264-9. PubMed ID: 2113222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The possible role of Limulus-amebocyte-lysate-reactive material in hemodialysis. First-use syndrome.
    Pearson FC
    Blood Purif; 1987; 5(2-3):115-22. PubMed ID: 3620119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethylene-oxide-induced IgE antibodies in dialysis patients after reuse of hollow fibre dialysers.
    Piazolo P; Brech WJ
    Lancet; 1986 Apr; 1(8486):918-9. PubMed ID: 2870388
    [No Abstract]   [Full Text] [Related]  

  • 10. Dialyzer hypersensitivity syndrome: possible role of allergy to ethylene oxide. Report of 4 cases and review of the literature.
    Caruana RJ; Hamilton RW; Pearson FC
    Am J Nephrol; 1985; 5(4):271-4. PubMed ID: 3901757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biocompatibility of artificial organs: an overview.
    Henderson LW; Chenoweth D
    Blood Purif; 1987; 5(2-3):100-11. PubMed ID: 3304344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute changes in C3a and C5a in an anaphylactoid reaction in hemodialysis patients.
    Suzuki Y; Uchida J; Tsuji H; Kuzuhara K; Hara S; Nihei H; Ogura Y; Otsubo O; Mimura N
    Tohoku J Exp Med; 1987 May; 152(1):35-45. PubMed ID: 3497472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellulose membranes--time for a change?
    Henderson LW; Chenoweth DE
    Contrib Nephrol; 1985; 44():112-26. PubMed ID: 3872769
    [No Abstract]   [Full Text] [Related]  

  • 14. IgE against ethylene oxide-altered human serum albumin (ETO-HSA) as an etiologic agent in allergic reactions of hemodialysis patients.
    Grammer LC; Patterson R
    Artif Organs; 1987 Apr; 11(2):97-9. PubMed ID: 3593052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loxoprofen sodium induces the production of complement C5a in human serum.
    Kumagai T; Yamaguchi N; Hirai H; Kojima S; Kodani Y; Hashiguchi A; Haida M; Nakamura M
    Int Immunopharmacol; 2016 Apr; 33():55-62. PubMed ID: 26854577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of dialyzer geometry on granulocyte and complement activation.
    Schaefer RM; Heidland A; Hörl WH
    Am J Nephrol; 1987; 7(2):121-6. PubMed ID: 3496792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dialyzer membranes: effect of surface area and chemical modification of cellulose on complement and platelet activation.
    Mahiout A; Meinhold H; Kessel M; Schulze H; Baurmeister U
    Artif Organs; 1987 Apr; 11(2):149-54. PubMed ID: 3036050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement C3 and C5 degradation products during hemodialysis treatment: study of an index of membrane bioincompatibility.
    Freyria AM; Leitienne P; Veysseyre CN; Bringuier JP; Traeger J
    Int J Artif Organs; 1988 Mar; 11(2):111-8. PubMed ID: 3259552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compartmental distribution of complement activation products in artificial kidneys.
    Cheung AK; Chenoweth DE; Otsuka D; Henderson LW
    Kidney Int; 1986 Jul; 30(1):74-80. PubMed ID: 3489123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement activation during hemodialysis: clinical observations, proposed mechanisms, and theoretical implications.
    Chenoweth DE
    Artif Organs; 1984 Aug; 8(3):281-90. PubMed ID: 6332607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.